Literature DB >> 18032546

Partial nephrectomy as a model for uremic cardiomyopathy in the mouse.

David J Kennedy1, Jihad Elkareh, Amjad Shidyak, Anna P Shapiro, Sleiman Smaili, Krishna Mutgi, Shalini Gupta, Jiang Tian, Eric Morgan, Samer Khouri, Christopher J Cooper, Sankaridrug M Periyasamy, Zijian Xie, Deepak Malhotra, Olga V Fedorova, Alexei Y Bagrov, Joseph I Shapiro.   

Abstract

Because of the plethora of genetic manipulations available in the mouse, we performed a partial nephrectomy in the mouse and examined whether the phenotypical features of uremic cardiomyopathy described in humans and rats were also present in the murine model. A 5/6 nephrectomy was performed using a combination of electrocautory to decrease renal mass on the left kidney and right surgical nephrectomy. This procedure produced substantial and persistent hypertension as well as increases in circulating concentrations of marinobufagenin. Invasive physiological measurements of cardiac function demonstrated that the 5/6 nephrectomy resulted in impairment of both active and passive left ventricular relaxation at 4 wk whereas tissue Doppler imaging detected changes in diastolic function after 6 wk. Morphologically, hearts demonstrated enlargement and progressive fibrosis, and biochemical measurements demonstrated downregulation of the sarcoplasmic reticulum calcium ATPase as well as increases in collagen-1, fibronectin, and vimentin expression. Our results suggest that partial nephrectomy in the mouse establishes a model of uremic cardiomyopathy which shares phenotypical features with the rat model as well as patients with chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032546      PMCID: PMC2742580          DOI: 10.1152/ajprenal.00472.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  19 in total

1.  Evaluation of left ventricular function in cardiomyopathic mice by tissue Doppler and color M-mode Doppler echocardiography.

Authors:  Yasuyuki Tsujita; Takahiro Kato; Mark A Sussman
Journal:  Echocardiography       Date:  2005-03       Impact factor: 1.724

2.  Histopathological study of time course changes in inter-renal aortic banding-induced left ventricular hypertrophy of mice.

Authors:  Hiroyuki Higashiyama; Masaki Sugai; Hirotaka Inoue; Kaori Mizuyachi; Hiroshi Kushida; Satoshi Asano; Mine Kinoshita
Journal:  Int J Exp Pathol       Date:  2007-02       Impact factor: 1.925

3.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

4.  Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice.

Authors:  Jin Zhang; Moo Yeol Lee; Maurizio Cavalli; Ling Chen; Roberto Berra-Romani; C William Balke; Giuseppe Bianchi; Patrizia Ferrari; John M Hamlyn; Takahiro Iwamoto; Jerry B Lingrel; Donald R Matteson; W Gil Wier; Mordecai P Blaustein
Journal:  J Physiol       Date:  2005-09-15       Impact factor: 5.182

5.  Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy.

Authors:  David J Kennedy; Sandeep Vetteth; Sankaridrug M Periyasamy; Mohamed Kanj; Larisa Fedorova; Samer Khouri; M Bashar Kahaleh; Zijian Xie; Deepak Malhotra; Nikolai I Kolodkin; Edward G Lakatta; Olga V Fedorova; Alexei Y Bagrov; Joseph I Shapiro
Journal:  Hypertension       Date:  2006-01-30       Impact factor: 10.190

6.  Quantitative assessment of regional myocardial function in mice by tissue Doppler imaging: comparison with hemodynamics and sonomicrometry.

Authors:  Igal A Sebag; Mark D Handschumacher; Fumito Ichinose; John G Morgan; Ryuji Hataishi; Ana Clara T Rodrigues; J Luis Guerrero; Wolfgang Steudel; Michael J Raher; Elkan F Halpern; Geneviève Derumeaux; Kenneth D Bloch; Michael H Picard; Marielle Scherrer-Crosbie
Journal:  Circulation       Date:  2005-05-16       Impact factor: 29.690

Review 7.  Murine models for the study of congestive heart failure: Implications for understanding molecular mechanisms and for drug discovery.

Authors:  Qing-Dong Wang; Mohammad Bohlooly-Y; Mohammad Bohlooly; Per-Ove Sjöquist
Journal:  J Pharmacol Toxicol Methods       Date:  2004 Nov-Dec       Impact factor: 1.950

8.  A reproducible model for chronic renal failure in the mouse.

Authors:  R F Gagnon; W P Duguid
Journal:  Urol Res       Date:  1983

Review 9.  Physiological role of the alpha1- and alpha2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site.

Authors:  Iva Dostanic-Larson; John N Lorenz; James W Van Huysse; Jon C Neumann; Amy E Moseley; Jerry B Lingrel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-03       Impact factor: 3.619

10.  Cellular basis of chronic ventricular remodeling after myocardial infarction in rats.

Authors:  G Olivetti; J M Capasso; L G Meggs; E H Sonnenblick; P Anversa
Journal:  Circ Res       Date:  1991-03       Impact factor: 17.367

View more
  57 in total

1.  Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis.

Authors:  Changxuan Liu; Yan Bai; Yiliang Chen; Yu Wang; Yoann Sottejeau; Lijun Liu; Xiaomei Li; Jerry B Lingrel; Deepak Malhotra; Christopher J Cooper; Joseph I Shapiro; Zi-jian Xie; Jiang Tian
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

2.  Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated With Right Ventricular Dysfunction and Nitrative Stress in Heart Failure.

Authors:  David J Kennedy; Kevin Shrestha; Brendan Sheehey; Xinmin S Li; Anuradha Guggilam; Yuping Wu; Michael Finucan; Alaa Gabi; Charles M Medert; Kristen Westfall; Allen Borowski; Olga Fedorova; Alexei Y Bagrov; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2015-08-14       Impact factor: 8.790

Review 3.  Targeting Na/K-ATPase Signaling: A New Approach to Control Oxidative Stress.

Authors:  Jiang Liu; Megan N Lilly; Joseph I Shapiro
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

4.  Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase.

Authors:  Arshani N Wansapura; Valerie Lasko; Zijian Xie; Olga V Fedorova; Alexei Y Bagrov; Jerry B Lingrel; John N Lorenz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-04-17       Impact factor: 4.733

Review 5.  Endogenous digitalis: pathophysiologic roles and therapeutic applications.

Authors:  Alexei Y Bagrov; Joseph I Shapiro
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10

Review 6.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

Review 7.  Endogenous cardiotonic steroids and salt-sensitive hypertension.

Authors:  Olga V Fedorova; Joseph I Shapiro; Alexei Y Bagrov
Journal:  Biochim Biophys Acta       Date:  2010-03-27

8.  Inhibition of urea transporter ameliorates uremic cardiomyopathy in chronic kidney disease.

Authors:  Akihiro Kuma; Xiaonan H Wang; Janet D Klein; Lin Tan; Nawazish Naqvi; Fitra Rianto; Ying Huang; Manshu Yu; Jeff M Sands
Journal:  FASEB J       Date:  2020-05-04       Impact factor: 5.191

9.  High salt intake causes adverse fetal programming--vascular effects beyond blood pressure.

Authors:  Grzegorz Piecha; Nadezda Koleganova; Eberhard Ritz; Annett Müller; Olga V Fedorova; Alexei Y Bagrov; Diana Lutz; Peter Schirmacher; Marie-Luise Gross-Weissmann
Journal:  Nephrol Dial Transplant       Date:  2012-03-19       Impact factor: 5.992

10.  Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin.

Authors:  Jiang Tian; Amjad Shidyak; Sankaridrug M Periyasamy; Steven Haller; Mohamed Taleb; Nasser El-Okdi; Jihad Elkareh; Shalini Gupta; Sabry Gohara; Olga V Fedorova; Christopher J Cooper; Zijian Xie; Deepak Malhotra; Alexei Y Bagrov; Joseph I Shapiro
Journal:  Hypertension       Date:  2009-11-02       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.